Factor | Univariate | Multivariate | ||||||
---|---|---|---|---|---|---|---|---|
 | HR | 95% CI | p Value | HR | 95% CI | p Value | ||
 |  | Lower | Upper |  |  | Lower | Upper |  |
Age (10 year) | 1.713 | 1.284 | 2.286 | < 0.001* | 1.947 | 1.366 | 2.775 | < 0.001 |
Male gender (%) | 1.899 | 1.014 | 3.557 | 0.045* | 4.267 | 1.985 | 9.171 | < 0.001 |
Dialysis duration (year) | 0.951 | 0.889 | 1.017 | 0.140 | Â | Â | Â | Â |
Body mass index (Kg/m2) | 1.000 | 0.914 | 1.093 | 0.995 | Â | Â | Â | Â |
Smoking index | 1.167 | 0.795 | 1.712 | 0.430 | Â | Â | Â | Â |
Kt/V | 0.116 | 0.033 | 0.416 | 0.001* | Â | Â | Â | Â |
Comorbidities (%) | Â | Â | Â | Â | Â | Â | Â | Â |
   Diabetes mellitus (%) | 2.125 | 1.138 | 3.967 | 0.018* |  |  |  |  |
   Hypertension (%) | 1.352 | 0.417 | 4.388 | 0.615 |  |  |  |  |
   Cardiovascular disease (%) | 2.256 | 1.204 | 4.227 | 0.011* |  |  |  |  |
   Prior stroke (%) | 2.588 | 0.797 | 8.406 | 0.114 |  |  |  |  |
   Malignancy (%) | 2.704 | 1.130 | 6.467 | 0.025* |  |  |  |  |
Hepatitis B infection (%) | 0.887 | 0.273 | 2.879 | 0.842 | Â | Â | Â | Â |
Hepatitis C infection (%) | 0.896 | 0.376 | 2.135 | 0.805 | Â | Â | Â | Â |
Medications | Â | Â | Â | Â | Â | Â | Â | Â |
   Antihypertensive agents (%) | 0.921 | 0.439 | 1.935 | 0.829 |  |  |  |  |
   ACE inhibitor/ARB (%) | 1.141 | 0.614 | 2.121 | 0.676 |  |  |  |  |
   Vitamin D3 (%) | 1.156 | 0.533 | 2.510 | 0.713 |  |  |  |  |
Laboratory data | Â | Â | Â | Â | Â | Â | Â | Â |
   Albumin (g/dL) | 0.136 | 0.044 | 0.425 | 0.001* | 0.032 | 0.008 | 0.126 | < 0.001 |
   Total cholesterol (mg/dL) | 0.997 | 0.989 | 1.006 | 0.509 |  |  |  |  |
   Triglycerides (mg/dL) | 1.001 | 0.999 | 1.003 | 0.442 |  |  |  |  |
   Sodium (mmol/L) | 0.937 | 0.841 | 1.044 | 0.236 |  |  |  |  |
   Chloride (mmol/L) | 0.984 | 0.869 | 1.114 | 0.801 |  |  |  |  |
   Bicarbonate (mmol/L) | 0.959 | 0.851 | 1.082 | 0.497 |  |  |  |  |
   ALT (U/L) | 1.001 | 0.978 | 1.024 | 0.963 |  |  |  |  |
   Alk-P (mg/dL) | 1.000 | 0.995 | 1.005 | 0.927 |  |  |  |  |
   Fasting glucose (mg/dL) | 1.004 | 1.000 | 1.008 | 0.030* |  |  |  |  |
   HbA1c (%) | 1.135 | 0.956 | 1.347 | 0.149 |  |  |  |  |
   WBC count (1000 per cumm) | 0.958 | 0.788 | 1.166 | 0.671 |  |  |  |  |
   Hemoglobin (g/dL) | 1.019 | 0.806 | 1.289 | 0.873 |  |  |  |  |
   High-sensitive CRP (mg/dL) | 1.432 | 1.062 | 1.932 | 0.019* | 1.534 | 1.072 | 2.195 | 0.019 |
   Ferritin (ng/mL) | 1.000 | 1.000 | 1.001 | 0.743 |  |  |  |  |
   Transferrin saturation (%) | 0.826 | 0.065 | 10.479 | 0.883 |  |  |  |  |
Peridialytic BP | Â | Â | Â | Â | Â | Â | Â | Â |
   predialytic SBP (mmHg) | 1.000 | 0.980 | 1.020 | 0.993 |  |  |  |  |
   postdialytic SBP (mmHg) | 1.008 | 0.990 | 1.026 | 0.393 |  |  |  |  |
   predialytic MAP (mmHg) | 0.992 | 0.959 | 1.027 | 0.648 |  |  |  |  |
   postdialytic MAP (mmHg) | 1.003 | 0.970 | 1.038 | 0.844 |  |  |  |  |
   predialytic DBP (mmHg) | 0.978 | 0.934 | 1.024 | 0.346 |  |  |  |  |
   postdialytic DBP (mmHg) | 0.981 | 0.932 | 1.032 | 0.452 |  |  |  |  |
   predialytic PP (mmHg) | 1.008 | 0.981 | 1.035 | 0.578 |  |  |  |  |
   postdialytic PP (mmHg) | 1.016 | 0.994 | 1.038 | 0.159 |  |  |  |  |
Peridialytic BP alterations (no as reference) | Â | Â | Â | Â | Â | Â | Â | Â |
   postdialytic SBP rise > 5 mmHg (yes/no) | 2.382 | 1.280 | 4.434 | 0.006* | 3.925 | 1.420 | 10.846 | 0.008 |
   postdialytic MAP rise > 5 mmHg (yes/no) | 1.762 | 0.929 | 3.344 | 0.083 |  |  |  |  |
   postdialytic DBP rise > 5 mmHg (yes/no) | 1.602 | 0.800 | 3.207 | 0.184 |  |  |  |  |
   postdialytic PP rise > 5 mmHg (yes/no) | 1.548 | 0.808 | 2.965 | 0.188 |  |  |  |  |
Ultrafiltration volume (Kg) | 1.355 | 0.944 | 1.944 | 0.099* | 3.470 | 2.045 | 5.889 | < 0.001 |
CT ratio > 50% (yes/no) | 8.960 | 2.322 | 34.572 | 0.001* | 7.560 | 2.048 | 27.912 | 0.002 |